Hyperhomocysteinemia, currently a public health problem, has been associated with the onset of critical diseases among elderly persons. Our aim in this study was to determine homocysteinemia levels in retired people. A cross sectional study was carried out among retired people in Bobo Dioulasso. Sociodemographic and clinico-biological variables were collected. Quantitative determination of total homocysteinemia in serum was carried out by a chemiluminescence microparticle immunoassay (CMIA). Three homocysteinemia levels were considered: moderate (16-30 µmol/L), intermediate (31-100 µmol/L), and severe (>100 µmol/L). Fisher's exact test was used to examine the significance of the association with a p-value of 0.05. We included a total of 71 retired people, with a median age of 64 years [minimum - maximum: 45 - 92 years], Hyperhomocysteinemia between [16-30 µmol/L [was observed in 16.90% (12/71) with a median homocysteinemia value equal to 18.71 µmol/L [minimum - maximum = 16.57 - 26.60 µmol/L]. Hyperhomocysteinemia was not significantly associated with increased blood pressure (p = 0.817), age group (p = 0.958), sex (p = 0.106), body mass index (0.053), estimated GFR (p = 0.590). A low frequency of moderate hyperhomocysteinemia was recorded in retired persons in Bobo-Dioulasso. An investigation of genetic polymorphisms associated with hyperhomocysteinemia could be considered.
Published in | Advances in Biochemistry (Volume 11, Issue 3) |
DOI | 10.11648/j.ab.20231103.11 |
Page(s) | 29-33 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Homocysteinemia, Retired Persons, Burkina Faso
[1] | Stuart Harvey Mudd, Flemming Skovby, Harvey L. Levy, Karen D. Pettigrew, Bridget Wilcken, Reed E. Pyeritz, G. Andria, Godfried H. J. Boers, Irvin L. Bromberg, Roberto Cerone, Brian Fowler, H. Gröbe, Hildgund Schmidt & Leslie Schweitzer. (1985). The natural history of homocystinuria due to cystathionine beta-synthase deficiency. American journal of human genetics, 37 (1), 1-31. |
[2] | Sanjay Kaul, Andrew A Zadeh & Prediman K Shah. (2006). Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. Journal of the American College of Cardiology, 48 (5), 914-923. https://doi.org/10.1016/j.jacc.2006.04.086 |
[3] | Andrew G. Bostom, Halit Silbershatz, Irwin H. Rosenberg, Jacob Selhub, Ralph B. D'Agostino, Philip A. Wolf, Paul F. Jacques & Peter W. F. Wilson. (1999). Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Archives of internal medicine, 159 (10), 1077-1080. https://doi.org/10.1001/archinte.159.10.1077. |
[4] | Jacques Simporè, Salvatore Pignatelli, Sergio Barlati, Mariano Malaguarnera & Salvatore Musumeci. (2000). Plasma homocysteine concentrations in a healthy population living in Burkina Faso. Current Therapeutic Research-Clinical and Experimental, 61 (9), 659-668. https://doi.org/10.1016/S0011-393X (00)88018-2. |
[5] | Rosa Chillemi, Jacques Simpore, Silvia Persichilli, Angelo Minucci, Alfonsina D'Agata & Salvatore Musumeci. (2005). Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso. Clinical chemistry and laboratory medicine, 43 (7), 765-771. https://doi.org/10.1515/CCLM.2005.131. |
[6] | Won-Cheol Park & Jeong-Hwan Chang. (2014). Clinical Implications of Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine Levels in Patients with Thromboembolic Occlusion. Vascular specialist international, 30 (4), 113-119. https://doi.org/10.5758/vsi.2014.30.4.113. |
[7] | Bogdan Cylwik & Lech Chrostek. (2011). Disturbances of folic acid and homocysteine metabolism in alcohol abuse. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, 30 (178), 295-299. |
[8] | Andrès Emmanuel, Affenberger Stéphane, Vinzio Stéphane, Noel Ether, Kaltenbach Georges & Schlienger Jean Louis. (2005). Carences en vitamine B12 chez l'adulte: étiologies, manifestations cliniques et traitement. La Revue de medecine interne, 26 (12), 938-946. https://doi.org/10.1016/j.revmed.2005.04.036 |
[9] | Ollo Da, Aoua Semde, Emmanuel Zongo, Emmanuel Kagambega, Arnaud Kouraogo, Wilfried Traore & Georges Anicet Ouedraogo. (2022). La denutrition proteino-energetique chez les personnes retraitees dans la ville de bobo-dioulasso. Journal de la Société de Biologie Clinique du Bénin; N° 040; 47-49. |
[10] | Phillip Son & Lindsay Lewis. (2022). Hyperhomocysteinemia. In StatPearls. StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554408/ |
[11] | Santica M Marcovina, Marlys L Koschinsky, John J Albers & Sonia Skarlatos. (2003). Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clinical chemistry, 49 (11), 1785–1796. https://doi.org/10.1373/clinchem.2003.023689. |
[12] | Emile K Amouzou, Nicodème W Chabi, Charles E Adjalla, Rosa M Rodriguez-Guéant, François Feillet, Christian Villaume, Ambaliou Sanni & Jean-Louis Guéant. (2004). High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C→T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa, The American Journal of Clinical Nutrition, 79 (4), 619-624. https://doi.org/10.1093/ajcn/79.4.619. |
[13] | Yide Yang, Yuan Zeng, Shuqian Yuan, Ming Xie, Yanhui Dong, Jian Li, Quanyuan He, Xiangli Ye, Yuan Lv, Carl-Friedrich Hocher, Bernhard K Kraemer, Xiuqin Hong & Berthold Hocher. (2021). Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China. BMJ open, 11 (12), e048575. https://doi.org/10.1136/bmjopen-2020-048575. |
[14] | Yu Wang, Xiaoying Li, Xianhui Qin, Yefeng Cai, Mingli He, Liming Sun, Jianping Li, Yan Zhang, Genfu Tang, Binyan Wang, Ningling Sun, Xin Xu, Lisheng Liu, Xiping Xu & Yong Huo. (2013). Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years. The British journal of nutrition, 109 (7), 1284–1293. https://doi.org/10.1017/S0007114512003157. |
[15] | Xue-Dong Liu, Bin Gao, Dong Sun, Ming Shi, Yue-Yun Ma, Zhi-Rong Liu, Bo Wang, Xiping Xu, Xin Xu, Qiu-He Ji & Gang Zhao. (2015). Prevalence of hyperhomocysteinaemia and some of its major determinants in Shaanxi Province, China: a cross-sectional study. The British journal of nutrition, 113 (4), 691-698. https://doi.org/10.1017/S0007114514004218 |
[16] | Victor Vitvitsky, Anna Prudova, Sally Stabler, Sanjana Dayal, Steven R Lentz & Ruma Banerjee. (2007). Testosterone regulation of renal cystathionine beta-synthase: implications for sex-dependent differences in plasma homocysteine levels. American journal of physiology. Renal physiology, 293 (2), F594–F600. https://doi.org/10.1152/ajprenal.00171.2007. |
[17] | Kallur Nava Saraswathy, Shipra Joshi, Suniti Yadav & Priyanka Rani Garg. (2018). Metabolic distress in lipid & one carbon metabolic pathway through low vitamin B-12: a population based study from North India. Lipids in health and disease, 17 (1), 96. https://doi.org/10.1186/s12944-018-0748-y. |
[18] | Angelika de Bree, WM Monique Verschuren, Henk J Blom & Daan Kromhout. (2001). Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. The American journal of clinical nutrition, 73 (6), 1027–1033. https://doi.org/10.1093/ajcn/73.6.1027. |
[19] | Djaara Hayat. (2019). Etude du Polymorphisme Génétique C677T et A1298C du gène MTHFR chez les patients ayant une Athérosclérose Coronarienne, dans une partie de la population des Aurès (Algérie). Université Batna-2- Mostefa Ben Boulaid. Algérie. Thèse. 66 (6), 1-145. DOI: 10.1684/abc.2008.0287. |
[20] | Noé Yameogo, Bapio Valérie Elvira, Jean Télesphore Bazie, Abdoul Karim Ouattara, Pouiré Yameogo, Tegwinde Rebeca Compaore, Dorcas Obiri-Yeboah, Florencia Wenkuuni Djigma, Simplice Damintoti Karou & Jacques Simpore. (2017). Major Polymorphisms of Genes Involved in Homocysteine Metabolism in Malaria Patients in Ouagadougou, Burkina Faso. Malaria research and treatment, 2017. https://doi.org/10.1155/2017/3468276 |
APA Style
Ollo Da, Souleymane Fofana, Emmanuel Zongo, Arnaud Kouraogo, Dieudonne Sanon, et al. (2023). Homocysteinemia Level Determination Among Retired People in Bobo Dioulasso, Burkina Faso. Advances in Biochemistry, 11(3), 29-33. https://doi.org/10.11648/j.ab.20231103.11
ACS Style
Ollo Da; Souleymane Fofana; Emmanuel Zongo; Arnaud Kouraogo; Dieudonne Sanon, et al. Homocysteinemia Level Determination Among Retired People in Bobo Dioulasso, Burkina Faso. Adv. Biochem. 2023, 11(3), 29-33. doi: 10.11648/j.ab.20231103.11
AMA Style
Ollo Da, Souleymane Fofana, Emmanuel Zongo, Arnaud Kouraogo, Dieudonne Sanon, et al. Homocysteinemia Level Determination Among Retired People in Bobo Dioulasso, Burkina Faso. Adv Biochem. 2023;11(3):29-33. doi: 10.11648/j.ab.20231103.11
@article{10.11648/j.ab.20231103.11, author = {Ollo Da and Souleymane Fofana and Emmanuel Zongo and Arnaud Kouraogo and Dieudonne Sanon and Adama Hermann Traore and Fatou Gueye Tall and Sanata Bamba and Georges Anicet Ouedraogo}, title = {Homocysteinemia Level Determination Among Retired People in Bobo Dioulasso, Burkina Faso}, journal = {Advances in Biochemistry}, volume = {11}, number = {3}, pages = {29-33}, doi = {10.11648/j.ab.20231103.11}, url = {https://doi.org/10.11648/j.ab.20231103.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20231103.11}, abstract = {Hyperhomocysteinemia, currently a public health problem, has been associated with the onset of critical diseases among elderly persons. Our aim in this study was to determine homocysteinemia levels in retired people. A cross sectional study was carried out among retired people in Bobo Dioulasso. Sociodemographic and clinico-biological variables were collected. Quantitative determination of total homocysteinemia in serum was carried out by a chemiluminescence microparticle immunoassay (CMIA). Three homocysteinemia levels were considered: moderate (16-30 µmol/L), intermediate (31-100 µmol/L), and severe (>100 µmol/L). Fisher's exact test was used to examine the significance of the association with a p-value of 0.05. We included a total of 71 retired people, with a median age of 64 years [minimum - maximum: 45 - 92 years], Hyperhomocysteinemia between [16-30 µmol/L [was observed in 16.90% (12/71) with a median homocysteinemia value equal to 18.71 µmol/L [minimum - maximum = 16.57 - 26.60 µmol/L]. Hyperhomocysteinemia was not significantly associated with increased blood pressure (p = 0.817), age group (p = 0.958), sex (p = 0.106), body mass index (0.053), estimated GFR (p = 0.590). A low frequency of moderate hyperhomocysteinemia was recorded in retired persons in Bobo-Dioulasso. An investigation of genetic polymorphisms associated with hyperhomocysteinemia could be considered.}, year = {2023} }
TY - JOUR T1 - Homocysteinemia Level Determination Among Retired People in Bobo Dioulasso, Burkina Faso AU - Ollo Da AU - Souleymane Fofana AU - Emmanuel Zongo AU - Arnaud Kouraogo AU - Dieudonne Sanon AU - Adama Hermann Traore AU - Fatou Gueye Tall AU - Sanata Bamba AU - Georges Anicet Ouedraogo Y1 - 2023/07/11 PY - 2023 N1 - https://doi.org/10.11648/j.ab.20231103.11 DO - 10.11648/j.ab.20231103.11 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 29 EP - 33 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20231103.11 AB - Hyperhomocysteinemia, currently a public health problem, has been associated with the onset of critical diseases among elderly persons. Our aim in this study was to determine homocysteinemia levels in retired people. A cross sectional study was carried out among retired people in Bobo Dioulasso. Sociodemographic and clinico-biological variables were collected. Quantitative determination of total homocysteinemia in serum was carried out by a chemiluminescence microparticle immunoassay (CMIA). Three homocysteinemia levels were considered: moderate (16-30 µmol/L), intermediate (31-100 µmol/L), and severe (>100 µmol/L). Fisher's exact test was used to examine the significance of the association with a p-value of 0.05. We included a total of 71 retired people, with a median age of 64 years [minimum - maximum: 45 - 92 years], Hyperhomocysteinemia between [16-30 µmol/L [was observed in 16.90% (12/71) with a median homocysteinemia value equal to 18.71 µmol/L [minimum - maximum = 16.57 - 26.60 µmol/L]. Hyperhomocysteinemia was not significantly associated with increased blood pressure (p = 0.817), age group (p = 0.958), sex (p = 0.106), body mass index (0.053), estimated GFR (p = 0.590). A low frequency of moderate hyperhomocysteinemia was recorded in retired persons in Bobo-Dioulasso. An investigation of genetic polymorphisms associated with hyperhomocysteinemia could be considered. VL - 11 IS - 3 ER -